InDevR Inc., a provider of analytical technologies for vaccines and biotherapeutics, has raised $9m in Series...
Up To Date
Latest News
Phage therapy specialist Vésale Bioscience gas bageds €1.8m from European Innovation Council (EIC) to fight...
Abionyx Pharma SA has announced positive data from Phase IIa testing of iCER-001, a recombinant apoA-I, as a...
BioNTech SE will pay £562m in cash to acquire its former partner InstaDeep Ltd. to expand its capabilities in...
Roche AG’s US subsidiary Genentech Inc has withdrawn its checkpoint inhibitor atezolizumab from the market...
Evosep APS has inked a $40m funding deal with Novo Holdings A/S that is aimed to advance standardised clinical...
Share
